Halozyme Therapeutics, Inc. (HALO)
NASDAQ·Healthcare·Biotechnology
$83.53
+1.53%
Mkt Cap $9.66B
Analyst Ratings
Buy
4
Hold
1
Sell
0
Price Target (23 analysts)
$88.25
Range $75.00 – $95.00
Implied Upside
+5.7%
Consensus $88.25 vs current $83.53
NASDAQ·Healthcare·Biotechnology
$83.53
+1.53%
Mkt Cap $9.66B
Buy
4
Hold
1
Sell
0
Price Target (23 analysts)
$88.25
Range $75.00 – $95.00
+5.7%
Consensus $88.25 vs current $83.53